Moheb Afzali , F. et al. 2026. BCc1, a Chelation-Based Nanomedicine, modulates splenic cytokine networks toward a profile associated with antitumor immunity in 4T1 breast tumor–bearing mice. Archives of Advances in Biosciences. 17, 1 (May 2026), 1–13. DOI:https://doi.org/10.22037/aab.v16i1.52004.